California-based biomedical firm LoneStar Heart Inc raised almost USD2.4 million in a Series C financing round from unnamed venture investors, which would be used for the company's heart therapies for advanced heart failure patients.
Olav B. Bergheim
Breaking News
Subscribe to VCpost newsletter
Most Popular
- China Hits 2 U.S. Defense Companies With Sanctions For Selling Military Weapons to Taiwan
- American Airlines Pilots Union Issues Urgent Safety Alert Over Maintenance Issues
- Social Security Benefits: 2025 COLA Predicted to Increase Amid Rising Inflation
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Convicted Fraudster Accused of Killing Wealthy Heiress Wife in Swimming Pool to Cash in on Over $4 Million Fortune
- Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight
- Innocent Female Uber Driver, 61, Shot Dead by 81-Year-Old Ohio Man Who Was Targeted by Scammers
